Stocks › BIOA

BioAge Labs, Inc.

BIOA·Nasdaq·United States United States·USD
$4.28
-0.43 (-9.13%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
BIOA
BioAge Labs, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BIOAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of BIOA by members of U.S. Congress · 4 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Suzan K. DelBeneSuzan K. DelBeneHouse · D · WA BIOABioAge Labs, Inc. · Stock Sale
$1,001 - $15,000
Jul 13, 2016 Jun 9, 2016 Filing ↗
Suzan K. DelBeneSuzan K. DelBeneHouse · D · WA BIOABioAge Labs, Inc. · Stock Purchase
$1,001 - $15,000
Nov 20, 2014 Oct 9, 2014 Filing ↗
Suzan K. DelBeneSuzan K. DelBeneHouse · D · WA BIOABioAge Labs, Inc. · Stock Purchase
$1,001 - $15,000
Nov 20, 2014 Oct 10, 2014 Filing ↗
Suzan K. DelBeneSuzan K. DelBeneHouse · D · WA BIOABioAge Labs, Inc. · Stock Purchase
$15,001 - $50,000
Aug 17, 2014 Jul 24, 2014 Filing ↗

Whale Activity

Position changes in BIOA reported for 2026-09-30 by 196 institutional filers
Increased: 52New: 44Held: 17Decreased: 44Closed: 34No prior filing: 5
  • Increased52
  • New44
  • Held17
  • Decreased44
  • Closed34
  • No prior filing5
FilerSharesValueChange
BlackRock, Inc.3.5M$25.1Mincreased
a16z Capital Management, L.L.C.3.2M$22.9Mheld
Sofinnova Investments, Inc.2.3M$16.3Mheld
Cormorant Asset Management, LP2.2M$15.9Mdecreased
MPM BioImpact LLC1.9M$13.2Mincreased
VANGUARD CAPITAL MANAGEMENT LLC1.6M$11.5Mincreased
STATE STREET CORP1.3M$9.6Mincreased
Octagon Capital Advisors LP1.3M$9.2Mdecreased
D. E. Shaw & Co., Inc.1.2M$8.2Mincreased
Polar Capital Holdings Plc1.1M$7.6Mdecreased
BRAIDWELL LP1.0M$7.3Mheld
GEODE CAPITAL MANAGEMENT, LLC921.5K$6.5Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by BIOA insiders, by quarter · Form 4
-500.0K-250.0K0250.0K500.0K2025 Q1: 02025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: -86.9K2025 Q42026 Q1: -282.4K2026 Q12026 Q2: -71.4K2026 Q22026 Q3: 02026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

117 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Barton ShanePrincipal Accounting Officer Sale −20.2K $25.19 $509K Jun 30, 2026 Form 4 ↗
Barton ShanePrincipal Accounting Officer Option exercise +7,861 $4.38 $34K Jun 30, 2026 Form 4 ↗
Barton ShanePrincipal Accounting Officer Option exercise +4,065 $4.30 $17K Jun 30, 2026 Form 4 ↗
Barton ShanePrincipal Accounting Officer Option exercise +4,000 $8.39 $34K Jun 30, 2026 Form 4 ↗
Barton ShanePrincipal Accounting Officer Option exercise +4,290 $10.85 $47K Jun 30, 2026 Form 4 ↗
Barton ShanePrincipal Accounting Officer Sale −42.4K $25.21 $1.1M Jun 29, 2026 Form 4 ↗
Barton ShanePrincipal Accounting Officer Option exercise +14.2K $4.38 $62K Jun 29, 2026 Form 4 ↗
Barton ShanePrincipal Accounting Officer Option exercise +8,958 $4.30 $39K Jun 29, 2026 Form 4 ↗
Barton ShanePrincipal Accounting Officer Option exercise +7,261 $8.39 $61K Jun 29, 2026 Form 4 ↗
Barton ShanePrincipal Accounting Officer Option exercise +9,301 $10.85 $101K Jun 29, 2026 Form 4 ↗
GOLDSTEIN DOV A MDChief Financial Officer Option exercise +3,542 $4.38 $16K Apr 23, 2026 Form 4 ↗
RUBIN PAUL DChief Medical Officer Sale −8,820 $17.81 $157K Apr 1, 2026 Form 4 ↗
RUBIN PAUL DChief Medical Officer Option exercise +3,383 $6.57 $22K Apr 1, 2026 Form 4 ↗
RUBIN PAUL DChief Medical Officer Option exercise +5,437 $4.11 $22K Apr 1, 2026 Form 4 ↗
RUBIN PAUL DChief Medical Officer Sale −7,433 $20.30 $151K Mar 2, 2026 Form 4 ↗
RUBIN PAUL DChief Medical Officer Option exercise +2,000 $6.57 $13K Mar 2, 2026 Form 4 ↗
RUBIN PAUL DChief Medical Officer Option exercise +5,433 $4.11 $22K Mar 2, 2026 Form 4 ↗
GOLDSTEIN DOV A MDChief Financial Officer Option exercise +3,542 $4.38 $16K Mar 1, 2026 Form 4 ↗
RUBIN PAUL DChief Medical Officer Sale −7,433 $18.75 $139K Feb 2, 2026 Form 4 ↗
RUBIN PAUL DChief Medical Officer Option exercise +2,000 $6.57 $13K Feb 2, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding BIOA · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.1M$28.0M0.00%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
915.6K$22.4M0.03%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
368.0K$9.0M0.01%Jun 30, 2026
iShares Russell 2000 Value ETF
iShares Trust
296.8K$7.3M0.05%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
SPDR SERIES TRUST
262.2K$6.4M1.50%Jun 30, 2026
iShares Biotechnology ETF
iShares Trust
223.3K$5.5M0.06%Jun 30, 2026
Fidelity Enhanced Small Cap Core ETF
Fidelity Covington Trust
171.4K$4.2M0.07%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
385.0K$3.5M0.01%Jul 31, 2026
iShares Micro-Cap ETF
iShares Trust
118.1K$2.9M0.19%Jun 30, 2026
iShares U.S. Pharmaceuticals ETF
iShares Trust
82.9K$2.0M0.18%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list BIOA's shares (CUSIP 09077V100), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Bihua ChenSCHEDULE 13G/A · passive (13G) · 2.2M shares4.9%
    Nov 16, 2026 · ↗
  • Cormorant Asset Management, LPSCHEDULE 13G/A · passive (13G) · 2.2M shares4.9%
    Nov 16, 2026 · ↗
  • Bihua ChenSCHEDULE 13G/A · passive (13G) · 2.4M shares5.4%
    Aug 14, 2026 · ↗
  • Cormorant Asset Management, LPSCHEDULE 13G/A · passive (13G) · 2.4M shares5.4%
    Aug 14, 2026 · ↗
  • Vinod KhoslaSCHEDULE 13G/A · passive (13G) · 1.8M shares4.0%
    May 15, 2026 · ↗
  • VK Services, LLCSCHEDULE 13G/A · passive (13G) · 1.8M shares4.0%
    May 15, 2026 · ↗
  • Khosla Ventures Opportunity Associates I, LLCSCHEDULE 13G/A · passive (13G) · 1.4M shares3.1%
    May 15, 2026 · ↗
  • Khosla Ventures Associates VI, LLCSCHEDULE 13G/A · passive (13G) · 437.2K shares1.0%
    May 15, 2026 · ↗
  • Khosla Ventures Opportunity I, LPSCHEDULE 13G/A · passive (13G) · 1.4M shares3.1%
    May 15, 2026 · ↗
  • Khosla Ventures VI, LPSCHEDULE 13G/A · passive (13G) · 437.2K shares1.0%
    May 15, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming BioAge Labs, Inc. as client

No lobbying filings found naming BioAge Labs, Inc. as the client.

Government Contracts

Federal awards to BioAge Labs, Inc. · USAspending

No federal contract awards found for BioAge Labs, Inc..

U.S. Patents

Recent USPTO applications naming BioAge Labs, Inc.

No USPTO patent applications found for BioAge Labs, Inc..

Annual Financials

From BIOA's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023
Revenue$9.0M$0n/a
Operating income-$92.8M-$78.2M-$48.4M
Net income-$80.6M-$71.1M-$63.9M
Diluted EPS-$2.24-$6.63-$38.17
Operating cash flow-$81.6M-$51.5M-$37.4M
Cash and equivalents$188.9M$354.3M$21.6M
Total assets$294.9M$358.2M$25.9M
Total liabilities$22.8M$35.1M$66.6M
Shareholders' equity$272.1M$323.1M-$173.4M

As BioAge Labs, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 24, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in BIOA's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsOct 2, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 12, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 8, 2026
    EDGAR ↗

About BioAge Labs, Inc.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersEMERYVILLE, CA
IncorporatedDE